Stock BLAC BELLEVUE LIFE SCIENCES ACQUISITION CORP.
Add to a list
To use this feature you must be a member
Log inSign up

News Bellevue Life Sciences Acquisition Corp.

Equities

BLAC

US0791741087

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-05-22 EDT 		5-day change 1st Jan Change
10.73 USD -.--% Intraday chart for Bellevue Life Sciences Acquisition Corp. -.--% +2.19%
05-15 Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-14 Bellevue Life Sciences Acquisition Corp. announced that it has received $0.14 million in funding CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.14 million in funding
CI
Bellevue Life Sciences Acquisitions Corp. Reminds Stockholders to Vote in Favor of Extension at May 14, 2024 Stockholder Meeting
PR
Bellevue Life Sciences Acquisition : New Financial Obligation - Form 8-K
PU
/C O R R E C T I O N -- OSR Holdings/
PR
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.05 million in funding
CI
Bellevue Life Sciences Acquisition Corp. announced that it has received $1.2 million in funding
CI
Bellevue Life Sciences Acquisition : New Financial Obligation - Form 8-K
PU
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.06 million in funding
CI
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.075 million in funding
CI
Bellevue Life Sciences Acquisition : OSR Holdings Co., Ltd. Enters Into Business Combination Agreement with Bellevue Life Sciences Acquisition Corp - Form 8-K
PU
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Certain Common Stock of Bellevue Life Sciences Acquisition Corp. are subject to a Lock-Up Agreement Ending on 9-AUG-2023.
CI
Bellevue Life Sciences Acquisition Plans to Take OSR Holdings Public in SPAC Merger Deal
MT
Bellevue Life Sciences Acquisition Corp. and OSR Holdings Sign an Exclusive Letter of Intent for a Business Combination
PR
Bellevue Life Sciences Acquisition Corp. entered into an exclusive, non-binding letter of intent to acquire OSR Holdings, Ltd.
CI
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.2 million in funding
CI
BELLEVUE LIFE SCIENCES ACQUISITION CORP. : Change in Directors or Principal Officers (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BLAC Stock
  4. News Bellevue Life Sciences Acquisition Corp.